Is Auxly a good stock to buy?

Valued at a market cap of $275 million, Auxly stock is down 32% from its 52-week high but it has also gained 52% in the last month. Auxly operates as a consumer-packaged-goods company in Canada and is focused on developing, manufacturing, and distributing cannabis products for recreational and wellness consumers.

Is Auxly Cannabis a good stock to buy now?

Bay Street forecasts Auxly Cannabis sales to rise by 49.5% year over year to $76 million in 2021 and by 74.3% to $132 million in 2022. Its loss per share is forecast to narrow from $0.14 in 2020 to $0.02 in 2022. We can see that the stock is valued at a forward price-to-2022 sales of just over two, making it extremely attractive right now.

How did Auxly's market share perform in Q3?

At the end of Q3, Auxly’s market share rose to 5.7%, up from 4.9% in Q2 of 2021. Bay Street forecasts Auxly Cannabis sales to rise by 49.5% year over year to $76 million in 2021 and by 74.3% to $132 million in 2022. Its loss per share is forecast to narrow from $0.14 in 2020 to $0.02 in 2022.